Patent details

EP2289503 Title: Treating muscle wasting with selective androgen receptor modulators

Basic Information

Publication number:
EP2289503
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP100756964
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Treating muscle wasting with selective androgen receptor modulators
French Title of Invention:
Traitement de l'amyotrophie à l'aide de modulateurs sélectifs du récepteur d'androgène
German Title of Invention:
Behandlung von Muskelschwund mit selektiven androgenen Rezeptormodulatoren
SPC Number:

Dates

Filing date:
05/12/2002
Grant date:
29/06/2016
EP Publication Date:
29/06/2016
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
02/03/2011
EP B1 Publication Date:
29/06/2016
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
05/12/2016
Expiration date:
05/12/2022
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
05/12/2002
 
 

Name:
University of Tennessee Research Foundation
Address:
211 Conference Center Building 600 Henley Street, Knoxville, TN 37996, United States (US)

Inventor

1

Name:
Dalton James T.
Address:
United States (US)

2

Name:
Steiner Mitchell S.
Address:
United States (US)

3

Name:
Miller Duane D.
Address:
United States (US)

4

Name:
Veverka Karen A.
Address:
United States (US)

Priority

Priority Number:
336185 P
Priority Date:
06/12/2001
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 31/32;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages